Why Am I Spotting Before My Period? What Brown Discharge Before Your Period Actually Means
- Jun 29
- 11 min read
If you have been managing brown spotting or discharge in the days before your period starts, you have probably been told one of two things. Either that it is normal, or that it is nothing to worry about.
Neither of those answers is quite right. Spotting before your period is extremely common. But common and normal are not the same thing. And there is something important sitting behind that spotting that most women, and many practitioners, never connect to the wider picture of hormonal health and long-term wellbeing. Luteal phase spotting has implications for your fertility, overall health and it also has repercussions for your long-term health post menopause.
Spotting before your period is your cycle flagging that progesterone needs attention. That flag is worth taking seriously for reasons that go far beyond monthly inconvenience.
What Is Luteal Phase Spotting?
The luteal phase is the second half of your menstrual cycle, the time between ovulation and the start of your period. In a healthy cycle it lasts twelve to fourteen days. During this phase, progesterone rises and remains elevated, maintaining the uterine lining in preparation for either a pregnancy or a period.
Luteal phase spotting refers to light bleeding or brown discharge that appears in the days before menstruation properly begins. A small amount of light spotting in the day or so immediately before your period arrives can be within the range of normal as the lining begins to transition. But three, four or more days of spotting before your period starts is the uterine lining beginning to shed before it should.
Brown discharge, as opposed to red bleeding, is typically older blood that has taken longer to exit the body. It often appears at the beginning or end of menstruation, or in the case of luteal phase spotting, as the lining begins breaking down prematurely in the days before the period arrives.
Why Progesterone Is Almost Always Involved
Progesterone is the hormone responsible for maintaining the stability of the uterine lining in the second half of your cycle. It rises after ovulation, peaks in the mid-luteal phase, and should remain adequately elevated until just before menstruation begins, at which point it drops, triggering the period.
When progesterone is insufficient, either not rising high enough after ovulation or dropping too quickly before menstruation, the lining cannot be maintained. It begins to break down prematurely. That is what you see as spotting.
This is why luteal phase spotting is so useful as a diagnostic signal. It is one of the clearest, most visible signs that progesterone is not doing what it needs to do in the second half of the cycle. It is not just an inconvenient symptom. It is your body communicating.
What Drives Low Progesterone
Progesterone production in the luteal phase depends on ovulation having occurred adequately. After ovulation, the empty follicle, now called the corpus luteum, produces progesterone for the remainder of the cycle. The quality of ovulation directly determines the quality of progesterone output that follows.
The drivers of low progesterone or a compromised luteal phase are varied, which is why identifying the specific cause in an individual matters so much for treatment outcomes. These can include:
Chronic stress and elevated cortisol: the stress hormone cortisol competes with progesterone for the same precursor, pregnenolone, and when cortisol demand is high, progesterone production is suppressed. This is sometimes called the pregnenolone steal.
Thyroid dysfunction: subclinical hypothyroidism, where thyroid function is impaired but within the standard reference range, is a frequently missed driver of luteal phase deficiency and irregular cycles.
Oestrogen dominance: elevated oestrogen relative to progesterone disrupts the hormonal balance of the luteal phase, even when progesterone itself is not critically low. The ratio matters as much as the absolute level.
Anovulatory cycles: cycles where ovulation has not occurred produce no corpus luteum and therefore no progesterone. These cycles can appear regular and go completely undetected without luteal phase progesterone testing or basal body temperature tracking.
Nutritional deficiencies: zinc, vitamin B6, magnesium, and vitamin C all play roles in corpus luteum function and progesterone synthesis. Deficiencies in these are common in women with luteal phase spotting.
Perimenopause: progesterone naturally begins to decline in the years before menopause, often before oestrogen does. Oestrogen can also be relatively high at times. Luteal phase spotting, along with shorter cycles and increased PMS, is frequently one of the earliest hormonal signs that the perimenopausal transition has begun.
"Luteal phase spotting is one of those symptoms that tells me a lot about what is happening hormonally, but it is rarely one thing. I look at the whole person, whether ovulation is occurring adequately, what the stress load looks like, whether thyroid function has been fully assessed, and whether there are nutritional gaps that might be affecting corpus luteum function. Getting to the right driver quickly is what makes treatment effective. And when we do, the spotting typically resolves within a few cycles."
- Gemma Knaap, Naturopath (BHSc Naturopathy, Certified Natural Fertility Educator, Gut Microbiome Analyst) | Southernwood Apothecary & Clinic.
Why This Matters for Fertility
If you are trying to conceive, luteal phase spotting is worth taking seriously sooner rather than later. The luteal phase is the window in which a fertilised egg travels to the uterus, implants, and a pregnancy begins to establish. Adequate progesterone is not optional for this process.
A luteal phase that is too short, or progesterone that drops too early, reduces the time available for implantation and withdraws the hormonal support a very early pregnancy depends on. The result can be failure to implant, or very early pregnancy loss that is indistinguishable from a late period. This is sometimes referred to as a biochemical pregnancy.
Women who experience recurrent early pregnancy loss, or who have been trying to conceive without success despite apparently normal investigations, should have a full luteal phase assessment, rather than relying on cycle length alone as a measure of cycle health.
The Longer View: What Your Cycle Health Means for Bone and Heart Health
This is perhaps the most significant and least discussed aspect of luteal phase health. And it comes from research that deserves far wider attention than it has received.
Dr Jerilynn Prior, Professor of Endocrinology and Metabolism at the University of British Columbia and Scientific Director of the Centre for Menstrual Cycle and Ovulation Research (CeMCOR), has spent decades studying the relationship between ovulatory health during the reproductive years and long-term bone and cardiovascular outcomes. Her research has produced findings that fundamentally challenge the way we think about the menstrual cycle and its role in women's lifelong health.
In a landmark study published in the New England Journal of Medicine, Prior and colleagues found that premenopausal women with ovulatory disturbances, including anovulatory cycles and short luteal phases within otherwise regular-appearing menstrual cycles, experienced significant spinal bone loss of two percent per year. Critically, these women had regular cycles and would never have been identified as having a hormonal problem by standard clinical measures.
This was a groundbreaking finding. It demonstrated that a woman can have a regular period every month and still be losing bone density silently, because the cycles are not adequately ovulatory and therefore not producing adequate progesterone. These findings have been confirmed in subsequent studies, with authors noting that bone mineral density loss of even one percent per year, if subclinical ovulatory disturbances persist over a reproductive lifetime of thirty to forty years, is likely to put women at significant risk of osteoporosis and fragility fractures later in life.
The mechanism behind this finding is the role of progesterone in bone formation. Oestrogen has long been known to inhibit bone resorption, the breakdown of existing bone. But progesterone stimulates osteoblast activity, the formation of new bone. Without adequate progesterone from regular ovulatory cycles, bone formation is impaired even when oestrogen levels are normal. Peak bone mass, which a woman achieves in her late twenties to early thirties, reflects not just her calcium intake but her history of ovulation and progesterone exposure across her reproductive years.
Dr Prior's research also extends to cardiovascular health. CeMCOR has documented research exploring the relationship between ovulatory disturbances and cardiovascular disease risk, with progesterone identified as playing a protective role that has historically been attributed solely to oestrogen. As Prior has stated, understanding and treating ovulation disturbances may hold the key to prevention of osteoporosis, cardiovascular disease, and breast cancer for women.
The implication of this body of research is significant. A woman who spends years with subclinical ovulatory disturbances, which may present as nothing more than luteal phase spotting and shorter premenstrual phases, may be accumulating a bone density deficit and cardiovascular risk that will not become apparent until well after menopause. By that point, the opportunity to protect those outcomes during the reproductive years has passed.
Peak bone mass and long-term cardiovascular health reflect a woman's history of ovulation. A cycle that looks regular on the outside may be silently under-producing progesterone for years.
What Common Versus Normal Actually Means
Luteal phase spotting is common because the drivers behind it, chronic stress, thyroid dysfunction, nutritional deficiencies and oestrogen dominance, are themselves extremely common in the lives of women navigating full, demanding lives. But the prevalence of a symptom does not make it inevitable, untreatable, or something to simply manage around.
It is also worth naming something about the way cycle symptoms are frequently dismissed in clinical settings. Women are told their cycles are normal when what is actually meant is that their cycles are within a statistically common range. The distinction between common and optimal is rarely made. And it matters, particularly when the long-term implications of suboptimal cycle health are as significant as the research suggests.
What to Do About Luteal Phase Spotting
The most important first step is identifying which driver, or combination of drivers, is responsible for the low progesterone or luteal phase insufficiency. Because the cause varies between women, so does the most effective approach.
A thorough assessment typically includes a review of cycle history and symptom patterns, mid-luteal phase progesterone testing ideally at day 21 of a 28-day cycle or seven days post-ovulation, thyroid function including free T3, free T4, and thyroid antibodies rather than TSH alone, nutritional assessment, stress and cortisol picture, and a broader hormonal panel to assess the oestrogen to progesterone ratio.
From there, treatment is targeted. Supporting ovulation quality, addressing the specific nutritional deficiencies present, managing the cortisol load, correcting thyroid function where needed, and using herbal and nutritional support for the corpus luteum and progesterone production all have roles depending on the individual circumstances.
When the right driver is identified and addressed, luteal phase spotting typically begins to improve within three cycles. It is one of the cycle symptoms I find most responsive to targeted naturopathic care.
Perimenopause and Spotting
For women in their late 30s and 40s who are noticing luteal phase spotting for the first time, or noticing it increasing in frequency, it is worth considering whether this is an early sign of the perimenopausal transition.
Progesterone begins to decline before oestrogen in the perimenopause, often several years before cycles become visibly irregular. Spotting, along with shorter cycles, heavier bleeding, worsening PMS, and sleep changes, can be among the first signs that this hormonal transition is underway. Supporting progesterone and overall hormonal balance during this window is not only relevant for cycle comfort. In light of Prior's research on progesterone and bone health, it is also a meaningful strategy for protecting long-term bone density in the menopausal years.
Your Cycle is Talking. It's Worth Listening.
Luteal phase spotting is one of those symptoms that sits in the background of a woman's life for months or years, managed but never explained. But it is a progesterone signal, almost always driven by something identifiable, whether that is chronic stress, thyroid dysfunction, nutritional deficiencies, anovulation, oestrogen dominance, or the early hormonal changes of perimenopause. It has real implications for fertility in the short term and, as Dr Jerilynn Prior's research makes clear, for bone density and cardiovascular health across a lifetime. None of that makes it inevitable, and none of it makes it untreatable.
When the right driver is identified and addressed, the cycle responds. If this sounds like your experience and you are ready to understand what is behind it, I would love to look at the full picture with you.
Telehealth consultations are available across Australia or in person in Albany. Click this link to book. 🌿
Frequently Asked Questions
Why am I spotting before my period?
Spotting before your period, also called luteal phase spotting, is almost always related to progesterone. Progesterone maintains the uterine lining in the second half of the cycle. When it is insufficient, whether because ovulation was inadequate, because of chronic stress, thyroid dysfunction, oestrogen dominance, or nutritional deficiencies, the lining begins to break down before menstruation is due. That premature breakdown is what you see as spotting. It is a hormonal signal worth investigating rather than accepting.
Is brown discharge before your period normal?
A very small amount of brown spotting in the day or so immediately before your period arrives can be within the range of normal as the lining transitions. Brown discharge appearing three or more days before your period starts is older blood from premature lining breakdown and is a sign that the luteal phase is not functioning optimally. It is common but it is not something to accept without understanding what is driving it.
Can spotting before my period affect my chances of getting pregnant?
Yes. The luteal phase is the window in which a fertilised egg implants and a pregnancy establishes, and adequate progesterone is essential for this process. A luteal phase that is compromised by low progesterone reduces both the time available for implantation and the hormonal support a very early pregnancy depends on. Women experiencing luteal phase spotting who are trying to conceive should have a mid-luteal progesterone level checked and a full assessment of luteal phase function, rather than relying on cycle regularity alone as evidence that everything is working well.
Does spotting before your period affect long-term health?
Research from Dr Jerilynn Prior at the Centre for Menstrual Cycle and Ovulation Research suggests it may have implications that extend well beyond the reproductive years. Ovulatory disturbances including short luteal phases have been associated with significant spinal bone loss of close to one percent per year in otherwise healthy premenopausal women with regular-appearing cycles. Over a reproductive lifetime, this accumulation of bone density loss is associated with increased risk of osteoporosis and fractures. Since progesterone stimulates new bone formation, adequate ovulatory cycles and adequate progesterone production during the reproductive years appear to be important for long-term bone and cardiovascular health.
What is a short luteal phase?
A short luteal phase is a luteal phase that lasts fewer than ten days, meaning the time between ovulation and the start of the period is insufficient for optimal progesterone production and uterine lining support. It can present as a cycle that appears shorter than usual, spotting before the period, or difficulty conceiving or maintaining very early pregnancies. It is diagnosed by tracking ovulation, typically through basal body temperature or cervical mucous tracking, rather than cycle length alone.
Can perimenopause cause spotting before your period?
Yes. Progesterone begins to decline in perimenopause, often before oestrogen does, and often several years before cycles become visibly irregular. Luteal phase spotting, along with shorter cycles, heavier periods, worsening PMS, and sleep changes, can be among the earliest signs that the perimenopausal transition is underway. Supporting progesterone and hormonal balance during this window has both cycle health and long-term bone health implications.
Can a naturopath help with luteal phase spotting?
Yes. A naturopath assesses the full hormonal and lifestyle picture to identify which specific drivers are behind the low progesterone or luteal phase insufficiency, and treats accordingly. Because the cause varies between women, a personalised approach consistently produces better outcomes than a generic supplement protocol. Luteal phase spotting is one of the cycle symptoms that responds well to targeted naturopathic care, typically resolving within a few cycles when the right driver is identified and addressed. Telehealth consultations are available across Australia. In person appointments are available in Albany, WA.
About the Author
Gemma Knaap is a naturopath, specialising in women's hormonal health, gut health, fertility, and reproductive wellbeing. She holds a Bachelor of Health Science in Naturopathy and is a Certified Natural Fertility Educator and Gut Microbiome Analyst. Gemma has an in person clinic in Albany, Western Australia and consults online Australia-wide via Telehealth.
References
Prior, J.C., Vigna, Y.M., Schechter, M.T. et al. (1990). Spinal bone loss and ovulatory disturbances. New England Journal of Medicine, 323, 1221-1227. https://doi.org/10.1056/NEJM199011013231801
Li, D., Hitchcock, C.L., Barr, S.I., Yu, T. and Prior, J.C. (2014). Negative Spinal Bone Mineral Density Changes and Subclinical Ovulatory Disturbances: Prospective Data in Healthy Premenopausal Women With Regular Menstrual Cycles. Epidemiologic Reviews, 36(1), 137-147. https://doi.org/10.1093/epirev/mxt012
Seifert-Klauss, V. and Prior, J.C. (2010). Progesterone and Bone: Actions Promoting Bone Health in Women. Journal of Osteoporosis, 2010, 845180. https://doi.org/10.4061/2010/845180
Centre for Menstrual Cycle and Ovulation Research (CeMCOR). Jerilynn Prior Biography. University of British Columbia. Retrieved from https://cemcor.ubc.ca/jerilynn-prior-biography/
Centre for Menstrual Cycle and Ovulation Research (CeMCOR). About Us. University of British Columbia. Retrieved from https://cemcor.ubc.ca/about-us/
Centre for Menstrual Cycle and Ovulation Research (CeMCOR). Preventive Powers of Ovulation and Progesterone: Ovulation and the Heart. Retrieved from https://cemcor.ubc.ca/wp-content/uploads/pre2025/uploads/7_Ovulation_and_the_Heart.pdf
Prior, J.C., Naess, M., Langhammer, A. et al. (2015). Ovulation Prevalence in Women with Spontaneous Normal-Length Menstrual Cycles: A Population-Based Cohort from HUNT3, Norway. PLOS One, 10(8), e0134473. https://doi.org/10.1371/journal.pone.0134473
Comments